SCHEMBL10199018

SCHEMBL10199018

O=C(O)C=CC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.76
▸ KDM4E B2RXH2 5/20 0.76
▸ HPGD P15428 2/20 0.76
▸ SMN1; SMN2 Q16637 4/20 0.71
▸ HTT P42858 3/20 0.71
▸ RECQL P46063 2/20 0.71
▸ MAPT P10636 3/20 0.69
▸ PKM P14618 1/20 0.69
▸ LPAR2 Q9HBW0 1/20 0.67
▸ LPAR3 Q9UBY5 1/20 0.67
▸ TRPM2 O94759 1/20 0.63
▸ LTB4R Q15722 1/20 0.63
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ TRPA1 O75762 6/20 0.61
▸ TRPM8 Q7Z2W7 3/20 0.61
▸ POLB P06746 2/20 0.60
▸ NPC1 O15118 2/20 0.60
▸ RAB9A P51151 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10936745 1.00 ALDH1A1 (0.76) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL11140030 0.87 KDM4E (0.81) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL11140025 0.87 KDM4E (0.81) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL12172767 0.86 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL10199005 0.84 TRPM2 (0.61) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL14206787 0.84 TRPM2 (0.61) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL11015286 0.83 HTT (0.68) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL11015276 0.83 HTT (0.68) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL11010949 0.83 HTT (0.68) ALDH1A1KDM4EHPGDSMN1; SMN2HTT
SCHEMBL11010956 0.83 HTT (0.68) ALDH1A1KDM4EHPGDSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115006-B2 Process for producing anthranilamide compound ISHIHARA SANGYO KAISHA, LTD. (JP) 2012-02-14 — — US disclosed
US-20100063293-A1 PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND ISHIHARA SANGYO KAISHA ,LTD. (JP) 2010-03-11 — — US disclosed
US-4320173-A REINFORCEMENT AND ADHESIVES FOR VULCANIZED PRODUCTS MONSANTO COMPANY (US) 1982-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063293-A1 PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND NAAA, AAAS, AADAC ALDH1A1 993/4885KDM4E 2955/4885HPGD 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback